The cleanroom technology market is expected to reach US$ 8,356.97 million by 2028 from US$ 5,233.63 million in 2021; it is estimated to grow at a CAGR of 6.9% from 2021 to 2028. A few factors such as increasing adoption in the biopharmaceuticals industry and technological advancements in cleanrooms are driving the growth of the market. However, the complexity and high costs associated with cleanrooms are hindering the market growth. Cleanroom is controlled environment that has a low level of pollutants such as air-borne microbes and particles, dust, aerosols, which contaminate the surrounding area. Industries use cleanroom technology to avoid the adverse effects that can be caused by the air pollutants and small particles in the product manufacturing process. Governments and private organizations have pumped funds to support research for niche healthcare products.Furthermore, increasing healthcare expenditure is another factor boosting the growth of the cleanroom technology market.
As per the report of the National Health Service (NHS), per capita health expenditure on health research, medical services, and central & other health services in England was increased to US$ 2,800 in 2016 from about US$ 2,500 in 2012. Moreover. continuous developments in the research in the country would drive the market growth during the forecast period. Besides, the pharmaceutical industry in Italy has grown dramatically in the past seven years.The export of pharmaceutical products from 2010 to 2017 has grown at a rate of 26% per year.
The industry in the country is significantly driven by the investments in the innovation of the supply chain. In 2019, the pharmaceutical sector increased a production value of over €34 billion, growing progressively in recent years.
Type Insights Based on type, the global cleanroom technology market is bifurcated into equipment and consumable.In 2020, the consumable segment held a larger share of the market.
However, the same segment is expected to register a higher CAGR in the market during 2021-2028.Cleanroom consumables are witnessing rise in demand for manufacturing quality products.
Product manufacturing industries often face contaminations in machinery, product flow, raw material, and personnel. Cleanroom technology helps in protecting the manufacturing processes and final products from contamination.
Construction Type Insights Based on construction type, the cleanroom technology market is segmented into standard cleanrooms, hardwall cleanrooms, softwall cleanrooms, and pass-through cabinets.The standard cleanrooms segment held the largest market share in 2021.
However, the hardwall cleanrooms segment is expected to hold a significant market share during the forecast period as the Hardwall cleanrooms hold higher pressure differentials than softwall cleanrooms to prevent particulate intrusion.Hardwalls are built with permanent infrastructure, services, and fabric.
A hardwall cleanroom provides the highest level of control, particularly when built with a recirculating air system rather than a single-pass system. In October 2019, Helvoet increased its cleanroom capacity in the Netherlands by installing new hardwall ISO 7 for its diagnostics customers.
End User Insights Based on end user, the cleanroom technology market is segmented into pharmaceutical industry, biotechnology industry, medical device manufacturers, hospitals, and others.The pharmaceutical industry segment held the largest market share in 2021, and it is expected to dominate the market by 2028.
The pharmaceutical industry segment is expected to hold a significant market share during the forecast period due to the presence of many biopharmaceutical companies, which leads to the high production of pharmaceutical products worldwide. Cleanroom technology is crucial for manufacturing sterile pharmaceutical products as it ensures the prevention of product contamination and operator’s safety when handling highly potent drug substances. A few major primary and secondary sources referred to while preparing the report on the global cleanroom technology market are the American National Standards Institute (ANSI), Center for Disease Control and Prevention (CDC), American Society for Testing and Materials (ASTM), and Nordic Association of Cleanroom Technology.
Our reports have been used by over 10K customers, including:
The aptamers market valued at an estimated USD 151 million in 2021 and is projected to reach USD 342 million by 2026, at a CAGR of 17.7% during the forecast period. Growth of aptamers market is attributed to factors such as increase in number of clinical trials for development of aptamer-based therapeutics, increase in awareness about advantages...
The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report provides comprehensive understanding and unprecedented access to the joint venture deals and agreements entered into by the worlds leading life science companies. This report provides details of the latest joint...
The Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report. This report provides details of the latest manufacturing and supply agreements announced in the pharmaceutical, biotechnology, device and diagnostic sectors. Fully revised and updated, the report...
The Global Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2021 report provides a detailed understanding and analysis of how and why companies enter clinical stage partnering deals and provides details of the latest clinical agreements announced in the healthcare sector. Understanding the flexibility...
The global western blotting market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.7% during the forecast period. Technological advancements, increasing government funding in the field of biomedical research, growing demand for personalized medicine, and the rising prevalence of HIV are the key factors...
411 pages •
By IQ4I Research & Consultancy Pvt. Ltd
• Nov 2021
Toxicology is the study of adverse effects that occur in living organisms and its environment due to chemicals, physical or biological substances at ambient exposure levels. Toxicology testing regulations are already in place for most of the developed countries across industries such as chemicals, pesticides, consumer...
The Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading biopharma companies. This report provides...
The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2014-2021 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of distribution agreements from...
The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2021 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets. The report provides a detailed understanding and analysis of how and why companies enter business, product,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.